The News Review:

- Linnea and Medicus Research Capture a First Place For 7-HMR Research…
- Hampton Corley Joins Clinipace as Vice President of Business Developme…
- David Levin Joins Clinipace as Vice President of Marketing
- Medidata Moves ‘Upstream’ with Fast Track Acquisition
- Quality of Life an Issue in Prostate Cancer Treatment
- Bloomberg.com: Investment Tools
- McGill University Health Centre Announces Important Support for…

Linnea and Medicus Research Capture a First Place For 7-HMR Research…
NPIcenter – NPIcenter (press release) – Mar 18, 2008
?In addition to winning the first place award the 7-HMR research will be published in an upcoming edition of the Journal for Alternative and Complementary Medicine. HMRlignan? the lignan product utilized in the study and manufactured by Linnea is a naturally occurring plant lignan HMR from the Norway spruce (picea abies). Clinical research has shown HMRlignan? to be a highly efficient enterolactone precursor. In addition to raising enterolactone levels HMRlignan? also provides significant blood plasma levels of the strong antioxidant and free radical scavenger HMR. About The Scripps Center for Integrative MedicineThe Scripps Center for Integrative Medicine offers the best of conventional and complementary medicine. Its annual Natural Supplements Conference for health care professionals featured a renowned faculty. Presentations included a clinically relevant overview of the latest information on natural supplements and nutritional medicine with an emphasis on disease states.

Hampton Corley Joins Clinipace as Vice President of Business Developme…
Carolina Newswire – Carolina Newswire (press release) – Mar 18, 2008
“It was very important that we bring in a sales leader that understands clinical data and has the experience discipline and desire to scale our business and build our sales organization” explains Porter. Prior to PSIMedica the healthcare analytics division of Bio-Reference Laboratories Corley served in different sales roles at Ariba GeoTel Communications (acquired by Cisco Systems) and PTC. About Clinipace: Clinipace is a clinical research software company providing a single integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies Clinical Research rganizations (CRs) and Academic Medical Centers (AMCs). ur platform called Tempo is delivered via a web-based on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms reducing project efforts and costs from startup to conclusion and empowering project stakeholders to make informed real-time decisions regarding their research. For more information on Clinipace please visit:.

David Levin Joins Clinipace as Vice President of Marketing
Carolina Newswire – Carolina Newswire (press release) – Mar 18, 2008
” Levin has served in a number of positions in the healthcare industry most recently as vice president at MEDSEEK and etrials. Levin also served as vice president of marketing at MercuryMD which was acquired by the Thomson Corporation in 2006 for a significant multiple. About Clinipace: Clinipace is a clinical research software company providing a single integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies Clinical Research rganizations (CRs) and Academic Medical Centers (AMCs). ur platform called Tempo is delivered via a web-based on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms reducing project efforts and costs from startup to conclusion and empowering project stakeholders to make informed real-time decisions regarding their research. For more information on Clinipace please visit:.

Medidata Moves ‘Upstream’ with Fast Track Acquisition
Bio-IT World – Mar 18, 2008
developer of the first protocol-authoring tool certified by the Clinical Data Interchange Standards Consortium (CDISC) eCliniqua learned during an exclusive interview with company representatives last week. The move will drive efficiencies across the clinical research process and further solidify Medidata?s position as leader in electronic data capture (EDC) technology says CE Tarek Sherif. The acquisition evolved out of a partnership between the companies that started early last year. The two organizations have a lot of ?core similarities? in terms of their goals and approaches to improving the conduct of clinical research says Sherif including a relentless drive for efficiencies through standardization and innovative technologies. With Fast Track products in its portfolio Medidata can accomplish that mission more broadly in terms of protocol development and trial planning contracting and negotiations. Fast Track received CDISC certification last year for its first-of-its-kind structured protocol-design tool.

Quality of Life an Issue in Prostate Cancer Treatment
Forbes – Mar 18, 2008
verall black men reported lower satisfaction with overalloutcomes including those related to quality of life. Spouses and partners were directly affected by thequality-of-life changes the research showed with their emotionalstate linked to the patient's own level of satisfaction withthe treatment outcome. "This will help people tailor discussion anddecision-making" said study senior author Dr. John Weiassociate chair for clinical research at the University of MichiganMedical School in Ann Arbor. "We know more than is typicallyused in practice. "More informationThere's more on prostate cancer therapies at the.

Bloomberg.com: Investment Tools
Bloomberg – Mar 18, 2008
Premier Research Group Plc (PRG LN): The manager ofclinical research for companies including Roche Holding AG andGlaxoSmithKline Plc said it is in the “final stages'' oftakeover talks with an unidentified suitor. Premier Researchclimbed 16 pence or 22. 2 percent to 88 pence. Ted Baker Plc (TBK LN): The U.

McGill University Health Centre Announces Important Support for…
Maketwire РMaketwire (Communiqu̩s de presse) РMar 18, 2008
caThe Research Institute of the McGill University Health Centre (RI MUHC) isa world-wide renowned biomedical and health-care hospital research centre. Located in Montreal Quebec the institute is the research arm of the MUHCa university health center affiliated with the Faculty of Medicine atMcGill University. The institute supports over 500 researchers nearly1000 graduate and post-doctoral students and operates more than 300laboratories devoted to a broad spectrum of fundamental and clinicalresearch. The Research Institute operates at the forefront of knowledgeinnovation and technology and is inextricably linked to the clinicalprograms of the MUHC ensuring that patients benefit directly from thelatest research-based knowledge. For further details visit:.